Estados Unidos · Plataformas y datos · TipRanks

Alembic Wins USFDA Approval for OTC Olopatadine Eye Drops

Publicado por TipRanks · Estados Unidos hace 10 h

Alembic Pharmaceuticals Limited ( ($IN:APLLTD) ) has issued an announcement. Alembic Pharmaceuticals, a vertically integrated generic-drug manufacturer with ...

Leer el artículo completo en TipRanks Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.tipranks.com)

Alembic Wins USFDA Approval for OTC Olopatadine Eye Drops

También te puede interesar

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

These stocks have soared the most today after the Democrats trounced Trump

Neuronetics (NASDAQ:STIM) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Alembic Wins USFDA Approval for OTC Olopatadine Eye Drops

Compartir

También te puede interesar

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

These stocks have soared the most today after the Democrats trounced Trump

Neuronetics (NASDAQ:STIM) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop